Virgin Atlantic Orders Drugs To Combat Avian Flu | Aero-News Network
Aero-News Network
RSS icon RSS feed
podcast icon MP3 podcast
Subscribe Aero-News e-mail Newsletter Subscribe

Airborne Unlimited -- Most Recent Daily Episodes

Episode Date

Airborne-Monday

Airborne-Tuesday

Airborne-Wednesday Airborne-Thursday

Airborne-Friday

Airborne On YouTube

Airborne-Unlimited-11.24.25

AirborneNextGen-
11.18.25

Airborne-Unlimited-11.19.25

Airborne-AffordableFlyers-11.20.25

AirborneUnlimited-11.21.25

LIVE MOSAIC Town Hall (Archived): www.airborne-live.net

Fri, Nov 04, 2005

Virgin Atlantic Orders Drugs To Combat Avian Flu

Carrier Purchases 10,000 Doses Of Antiviral Tamiflu

Britain's Virgin Atlantic Airways has ordered a stockpile of the antiviral drug Tamiflu to be used in case a human outbreak of avian flu sweeps through areas in which the carrier operates.

The move, billed "as a purely precautionary measure" in a Time magazine report, comes as cases of "bird flu" have already been reported in poultry in China, Malaysia and Japan.

While Virgin did not cite the specific amount ordered by the carrier, Time reported the 10,000 figure comes from Sir Richard Branson himself, who owns a majority stake of the airline he created in 1984.

Virgin does not currently serve the countries that have reported human cases of the disease so far -- Cambodia, Indonesia, Vietnam, and Thailand -- although the carrier does fly into Hong Kong, which reported human outbreaks of a bird flu strain eight years ago.

Virgin stresses there is no need to alter its routes at this time. "Virgin Atlantic is closely monitoring the spread of avian flu and is in regular contact with the (British) and U.S. governments," the company said Wednesday.

"At this stage, there is no need to change any advice to passengers traveling with Virgin Atlantic, or to alter any of the airline's procedures."

Virgin Atlantic said it was also "evaluating a range of other systems and measures" -- good thing, too, as it is unlikely any supplies of Tamiflu needed by the carrier would be available anytime soon.

The antiviral drug -- that is only produced by the Swiss pharmaceutical company Roche Group -- is already on backorder worldwide. According to the World Health Organization, it will take 10 years at current production rates to treat 20 percent of the world's population.

FMI: www.virginatlantic.com, www.who.org

Advertisement

More News

Aero-News: Quote of the Day (11.27.25)

“Achieving PMA for the S-1200 Series magnetos is another step in expanding our commitment to providing the aviation community with the most trusted and durable ‘firewal>[...]

Airborne 11.26.25: Bonanza-Baron Fini, Archer v LA NIMBYs, Gogo Loses$$$

Also: Bell 505 on SAF, NYPA Gets Flak For BizAv 'Abuse', FAA Venezuela Caution, Horizon Update Textron Aviation has confirmed it will be ending production of the Beechcraft Bonanza>[...]

FAA Seeks Info For New Brand-New ATC Platform

State-Of-The-Art Common Automation Platform To Replace Legacy Systems The FAA has issued a Request for Information (RFI) regarding the initiative of the Trump Administration and U.>[...]

USAF Reaper Drone Crashes Off the South Korean Coast

Kunsan Air Base Reported the Accident During Routine Operations The US Air Force has confirmed that it lost an MQ-9 Reaper drone to the South Korean waters on November 24. The airc>[...]

Hartzell Engine Tech Magneto Gains FAA-PMA

PowerUp S-1200 Series Approved, Available for 4- And 6-Cylinder Engines Hartzell Engine Tech announced it received FAA Parts Manufacturer Approval for its PowerUp S-1200 Series air>[...]

blog comments powered by Disqus



Advertisement

Advertisement

Podcasts

Advertisement

© 2007 - 2025 Web Development & Design by Pauli Systems, LC